Gerard Hascoet
Executive Chairman @ MD Start
Paris, France
Gerard Hascoet is a Series A investor at MD Start in Paris focused on Health Care and Medical Device. Gerard Hascoet is the Executive Chairman of MD Start.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Gerard Hascoet invests in
Stages Gerard Hascoet invests in
Countries Gerard Hascoet invests in
Investment Focus
Industry
- Health Care 2 (50%)
- Medical Device 2 (50%)
- Manufacturing 1 (25%)
- Emergency Medicine 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
- Series C 1 (25%)
- Series D 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LimFlow SA
|
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularizationefforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach. | $39.3M / Series D / Apr 05, 2022 | |
Corwave
|
The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $43.2M / Series C / Jan 06, 2021 | |
|
Corwave
|
The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $17.1M / Series B / Nov 04, 2016 | |
|
Corwave
|
The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $3.5M / Series A / Jul 10, 2013 |
Co-Investors
About MD Start
MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.
MD Start Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gerard Hascoet
Executive Chairman
|
|||
Anne Osdoit
Partner
|
|||
Tim Lenihan
Partner / Entrepreneur In Residence
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Gerard Hascoet invest in?
Gerard Hascoet invests primarily in Health Care, Medical Device and Manufacturing startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Gerard Hascoet last invest?
The most recent investment recorded for Gerard Hascoet closed in Apr 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
